These findings not only enhance our understanding of the role of TRPM4 and TRPM6 in colorectal cancer heterogeneity, particularly their potential as subtype-specific and stage-associated biomarkers, but also lay a foundation for future studies exploring their mechanistic involvement in CMS subtype differentiation and disease progression. The gene discussed is TRPM6; the disease is colorectal cancer.